Lysozyme Market Size & Outlook, 2026-2034

Lysozyme Market Overview

The global lysozyme market size was valued at USD 585.12 million in 2025 and is estimated to grow from USD 627.36 million in 2026 to reach USD 1,124.32 million by 2034, growing at a CAGR of 7.65% during the forecast period (2026–2034). The market is driven by rising demand for natural preservatives, growing awareness of food safety, increasing adoption in pharmaceuticals and healthcare, and expanding applications in plant-based and vegan products, supporting sustainable, clean-label solutions worldwide.

Key Market Trends & Insights

• North America held the largest market share.
• By Source, the egg white derived lysozyme segment held the highest market share of over 60%.
• By Form, the liquid lysozyme segment is expected to witness the fastest CAGR of 7.97%.
• By Applications, the food and beverage segment held the highest market share of over 40%.
• By End-Use, the pharmaceutical and healthcare segment is expected to witness the fastest CAGR of 6.48%.

Market Size & Forecast

• 2025 Market Size: USD 12 million
• 2034 Projected Market Size: USD 1,124.32 million
• CAGR (2026-2034): 7.65%
• North America: Largest market in 2024

Lysozyme is a naturally occurring enzyme with strong antimicrobial properties, capable of breaking down bacterial cell walls. Widely used in food, pharmaceutical, and biotechnology sectors, it preserves dairy, meat, and beverage products, enhances shelf life, and supports food safety. In healthcare, lysozyme is applied in dietary supplements, wound care, and nasal sprays for immune support. Its versatility extends to animal feed, cosmetics, and research applications, making it a crucial bioactive ingredient across multiple industries.

The lysozyme market is fueled by increasing demand in pharmaceuticals for antibacterial and therapeutic formulations, as well as growing use in animal nutrition to improve health and productivity. Opportunities also arise from expanding R&D in biotechnology, where lysozyme serves as a model enzyme in molecular studies and enzyme engineering. Moreover, innovations in functional foods and nutraceuticals create avenues for lysozyme integration, while its application in advanced wound care and medical devices offers further growth potential across diverse global market.

Latest Market Trends

Rising demand for natural and clean-label food preservatives

The global lysozyme market is witnessing steady growth as consumers increasingly prefer natural and clean-label food preservatives. With growing health consciousness and awareness about the harmful effects of synthetic additives, food manufacturers are adopting lysozyme to ensure product safety, extended shelf life, and compliance with clean-label requirements.

Moreover, the rising popularity of minimally processed and organic foods further boosts lysozyme demand. Its effectiveness as an antimicrobial agent makes it a preferred choice for dairy, meat, and ready-to-eat products. This trend aligns with the global shift toward sustainable, chemical-free food solutions, driving long-term market adoption across industries.

To get more insights about this report Download Free Sample Report

Market Driver

Growing awareness of food safety and hygiene standards

The global lysozyme market is being strongly driven by increasing awareness of food safety and hygiene standards. Consumers are becoming more conscious of harmful additives and the overall quality of the food they consume, prompting manufacturers to seek natural preservatives.

• For instance, in 2025, China's National Health Commission unveiled a comprehensive legislative plan to develop or revise 44 priority food safety standards, covering food additives, hygiene requirements, and testing methods. This initiative highlights the nation’s commitment to improving food safety and mirrors the global trend toward stricter hygiene regulations.

As a result, food producers are increasingly adopting lysozyme to ensure product safety, meet regulatory compliance, and cater to consumer demand for clean-label products.

Market Restraint

High production costs of lysozyme extraction and purification

The lysozyme market faces a key restraint due to the high costs associated with extraction and purification. Since lysozyme is primarily derived from egg whites, the process requires advanced technology and labor-intensive methods, driving up production expenses. This limits large-scale availability and makes lysozyme less competitive than synthetic preservatives. Moreover, the reliance on costly raw materials further restricts affordability, creating barriers for small and medium manufacturers and slowing adoption in price-sensitive markets.

Market Opportunity

Expansion of lysozyme applications in plant-based and vegan alternatives

The global lysozyme market is witnessing growing opportunities with the expansion of its applications in plant-based and vegan alternatives. As consumer demand for sustainable and animal-free products rises, lysozyme’s functional properties are being explored beyond traditional uses in food and pharmaceuticals.

• For example, in 2025, researchers published a study in npj Science of Food highlighting the potential of microbial lysates as liquid egg substitutes. The study demonstrated that microbial lysates, including those derived from Escherichia coli Nissle 1917, can form gels and stable foams when heated, effectively mimicking the properties of liquid eggs.

This innovation offers a promising, sustainable alternative for various culinary applications, opening new avenues for lysozyme in plant-based and vegan product development globally.

Regional Analysis

North America holds a dominant position, driven by high consumer awareness regarding food safety, hygiene, and clean-label ingredients. The region’s advanced food processing industry extensively uses lysozyme for dairy, meat, and beverage applications. Moreover, strong pharmaceutical and healthcare sectors fuel demand for lysozyme-based supplements and therapeutic formulations. Increasing investments in R&D for plant-based and vegan alternatives further contribute to market growth. Moreover, stringent regulations on food preservatives and natural antimicrobial agents also encourage the adoption of lysozyme across multiple end-use segments, strengthening its market dominance.

• The US market is experiencing significant growth, with projections indicating a substantial increase in market size. Companies such as Bioseutica, Bouwhuis Enthoven, and Chr. Hansen are key player in the U.S. market, supplying egg white-derived lysozyme for applications in food preservation and pharmaceuticals. The country's strong regulatory environment and consumer preference for natural ingredients contribute to the expanding demand for lysozyme-based products.
• Canada’s lysozyme market is also on an upward trajectory, driven by the increasing use of lysozyme in food processing and pharmaceuticals. Companies like Biorbyt, LSBio, and Invitrogen are prominent suppliers of lysozyme detection kits and reagents, supporting research and quality control in various industries. Moreover, the Canadian market benefits from a supportive regulatory framework and a growing emphasis on natural preservatives in food products.

Europe: Significantly Growing Region

Europe represents a significantly growing region for lysozyme, driven by increasing demand for natural preservatives and clean-label solutions across the food and beverage sectors. Rapid adoption of plant-based and vegan alternatives creates new opportunities for microbial and plant-derived lysozyme. Strong regulatory support for food safety and hygiene, combined with the region’s advanced pharmaceutical industry, further fuels market growth. Moreover, expansion in dairy, processed food, and supplement applications, along with heightened consumer awareness of sustainable and safe ingredients, underpins the region’s consistent market development and rising lysozyme consumption.

• The UK market is experiencing steady growth, driven by the increasing demand for natural preservatives in food products. Companies like Bioseutica and Bouwhuis Enthoven are active in supplying egg white-derived lysozyme to the UK market. The country's stringent food safety regulations and consumer preference for clean-label products further bolster the demand for lysozyme-based solutions.
• Germany’s lysozyme market is characterized by the country's strong pharmaceutical and food processing sectors, which drive the demand for lysozyme, particularly in applications requiring natural preservatives. Companies such as Bioseutica and Chr. Hansen play a pivotal role in supplying lysozyme to the German market. Germany's commitment to innovation and quality standards supports the expanding use of lysozyme in various sectors.

Source Insights

Egg white-derived lysozyme continues to dominate the global market due to its high antimicrobial efficacy and versatility. It is widely used in food preservation, particularly in dairy, meat, and beverage products, where it prevents bacterial contamination and extends shelf life. Its natural origin and proven safety profile make it the preferred choice for both traditional and plant-based formulations. The consistent demand for clean-label and minimally processed foods further strengthens its market dominance.

Form Insights

Liquid lysozyme holds a dominant position because of its ease of incorporation into various food and pharmaceutical formulations. Its soluble nature ensures uniform distribution in beverages, dairy products, and liquid supplements, enhancing antimicrobial effectiveness. Moreover, liquid lysozyme allows precise dosing and processing efficiency, making it highly suitable for industrial-scale applications. Manufacturers prefer it over powdered forms for processes requiring rapid solubility, consistent activity, and better stability.

Applications Insights

The food and beverage sector remains the largest application segment, driven by the growing demand for natural preservatives and clean-label ingredients. Lysozyme is extensively used in cheese, wine, and dairy products to inhibit spoilage microorganisms and extend shelf life. Its antimicrobial properties also support plant-based and alternative protein products, meeting consumer preferences for safe, minimally processed foods. The ongoing focus on food safety, hygiene, and regulatory compliance continues to reinforce its dominance in this segment.

End-Use Insights

Pharmaceutical and healthcare applications dominate lysozyme consumption due to its therapeutic and antimicrobial properties. Lysozyme is used in wound care, nasal sprays, and dietary supplements for immune support and infection control. Its efficacy in preventing bacterial growth and promoting overall health positions it as a critical ingredient in medical formulations. Increasing healthcare awareness, rising prevalence of infectious diseases, and demand for natural, biocompatible compounds further drive its adoption in pharmaceutical and healthcare products globally.

Company Market Share

Leading market players are focusing on product innovation, expanding applications in food, beverage, pharmaceutical, and plant-based sectors. Companies are investing in R&D to develop microbial and plant-derived lysozyme alternatives, improve formulation stability, and enhance functional properties such as antimicrobial activity and foaming ability. Strategic initiatives also include expanding production capacities, entering emerging markets, and strengthening partnerships with food processors and healthcare manufacturers.

Danisco (DuPont)

Danisco A/S was established in 1989 in Copenhagen, Denmark, through the merger of Danish Sugar and Dansk Handels- og Industri Company. Specializing in enzymes, bioingredients, and excipients, Danisco became a global leader in food production and industrial biotechnology. In 2011, DuPont acquired Danisco for $6.3 billion to enhance its capabilities in food additives and enzymes. Subsequently, Danisco's operations were integrated into DuPont's Nutrition & Biosciences division, which later merged with IFF in 2021, forming DuPont Danisco.

• As of August 2025, DuPont continues to leverage its Danisco division's capabilities to advance lysozyme applications, particularly in food preservation and natural antimicrobial solutions. The company has been recognized for its innovative contributions to the field, including winning three 2025 R&D 100 Awards in the Mechanical/Materials category, highlighting its ongoing commitment to research and development in enzyme technologies.

List of key players in Lysozyme Market

1. Danisco (DuPont)
2. Brenntag AG
3. Advanced Enzymes
4. Enzyme Development Corporation
5. Henan Dida Biological Products
6. Hangzhou Ruibang Biotechnology
7. Novozymes
8. Amano Enzyme Inc.
9. Tianjin Binhai Chemical Industry Group
10. Lysobact
11. AB Enzymes
12. Jinan Shengquan New Materials
13. Changsha Zhengbang Bio-technology
14. Nihon Pharmaceutical
15. Shaanxi Huike Botanical Development
16. Shandong Longli Bio-Technology
17. DSM
18. Jinan Jianfeng Natural Product
19. Jiangsu Yonghui Biotechnology
20. Qufu Shengjin Biological Engineering

To get more findings about this report Download Market Share

Recent Development

• September 2025 - A study published in Analytical Chemistry introduces a wearable fluorescent eye patch that noninvasively monitors lysozyme levels in tears, offering a real-time tool for eye health diagnostics. Developed by researchers at the Institute of Solid State Physics, the patch utilizes a multi-emission metal-organic framework (MOF) hydrogel composed of europium (Eu³⁺) and dysprosium (Dy³⁺) ions.